{"pageContent": "This article examines prostate cancer as a target for immunotherapy and investigates active immunotherapy for prostate cancer, combining conventional therapy with active immunotherapy, immune modulators (brakes and accelerators), and monoclonal antibodies.", "metaData": {"source": "Prostate cancer in sexual minorities and the influence of HIV status\nhttps://pubmed.ncbi.nlm.nih.gov/31101896/"}}